Drug Profile
Metronidazole vaginal gel - AbbVie
Alternative Names: GW 05; Nuvessa; Product 55394Latest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Graceway Pharmaceuticals
- Developer AbbVie
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Skin disorder therapies; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Bacterial vaginosis
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
- 24 Mar 2014 Registered for Bacterial vaginosis in USA (Vaginal, 1.3%) - First global approval